Entry - #616570 - CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3 - OMIM
# 616570

CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
13q33.1 Cerebrooculofacioskeletal syndrome 3 616570 AR 3 ERCC5 133530
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Other
- Intrauterine growth retardation
HEAD & NECK
Head
- Microcephaly
Face
- Micrognathia
Ears
- Low-set ears
Eyes
- Microphthalmia (in some patients)
Mouth
- Cleft palate (in some patients)
SKELETAL
- Arthrogryposis
Hands
- Clenched fists
Feet
- Rocker bottom feet
- Talipes equinovarus
SKIN, NAILS, & HAIR
Skin
- Sun sensitivity
MUSCLE, SOFT TISSUES
- Edema
NEUROLOGIC
Central Nervous System
- Lack of psychomotor development
- Immature cerebral sulcation (in some patients)
- Posterior fossa abnormalities (in some patients)
PRENATAL MANIFESTATIONS
Movement
- Decreased fetal movements
LABORATORY ABNORMALITIES
- Increased cellular UV sensitivity
MISCELLANEOUS
- Early death
- One consanguineous Pakistani family and 1 unrelated patient have been reported (last curated September 2015)
MOLECULAR BASIS
- Caused by mutation in the excision repair, complementing defective, in Chinese hamster, 5 gene (ERCC5, 133530.0003)

TEXT

A number sign (#) is used with this entry because of evidence that cerebrooculofacioskeletal syndrome-3 (COFS3) is caused by homozygous mutation in the ERCC5 gene (133530) on chromosome 13q33.

Biallelic mutations in the ERCC5 gene can also cause Xeroderma pigmentosum, group G and/or Cockayne syndrome (278780).


Description

Cerebrooculofacioskeletal syndrome is a severe, progressive neurologic disorder characterized by prenatal onset of arthrogryposis, microcephaly, and growth failure. Postnatal features include severe developmental delay, congenital cataracts (in some), and marked UV sensitivity of the skin. Survival beyond 6 years of age is rare. COFS represents the severe end of the spectrum of disorders caused by mutations in nucleotide excision repair (NER) genes, with Cockayne syndrome and xeroderma pigmentosum being milder NER-related phenotypes (summary by Drury et al., 2014).

For a phenotypic description and a discussion of genetic heterogeneity of cerebrooculofacioskeletal syndrome, see COFS1 (214150).


Clinical Features

Hamel et al. (1996) and Nouspikel et al. (1997) studied a male who was born to healthy first-cousin Moroccan parents and had extremely severe early-onset Cockayne syndrome leading to death at 7 months of age. Graham et al. (2001) referred to the case reported by Hamel et al. (1996) as one of cerebrooculofacioskeletal syndrome. The patient showed prenatal-onset growth deficiency, severe microcephaly, microphthalmia with no cataracts, cleft palate, cutaneous photosensitivity, and brain atrophy with no calcifications. Skin fibroblasts showed extreme cellular sensitivity to UV, comparable to that in classic XP.

Drury et al. (2014) reported a family of Pakistani ancestry in which 5 fetuses conceived to 3 pairs of first cousins presented with abnormal ultrasound findings in the second trimester, including contractures and microcephaly. All pregnancies were terminated and underwent autopsy. Variable intracerebral findings included 2 instances of ventriculomegaly, 2 of delayed cerebral sulcation, and 2 of cerebellar hypoplasia/posterior fossa abnormalities. The 1 fetus that survived beyond 24 weeks developed progressive edema. None of the fetuses had cataracts.


Inheritance

The transmission pattern of COFS3 in the family reported by Drury et al. (2014) was consistent with autosomal recessive inheritance.


Mapping

By linkage analysis of a consanguineous Pakistani kindred in which 5 fetuses were affected with COFS, Drury et al. (2014) found linkage to a 9.3-Mb region on chromosome 13q32.3-q33.3 (lod score of 5.0).


Molecular Genetics

In a boy, born of consanguineous Moroccan parents, with COFS originally reported by Hamel et al. (1996), Nouspikel et al. (1997) identified a homozygous truncating mutation in the ERCC5 gene (133530.0003).

In 4 fetuses from a large consanguineous Pakistani kindred with COFS3, Drury et al. (2014) identified a homozygous truncating mutation in the ERCC5 gene (133530.0016) predicting the loss of the C terminus. The mutation, which was found by a combination of linkage analysis and exome sequencing, segregated with the disorder in the family. Functional studies of the variant were not performed.


REFERENCES

  1. Drury, S., Boustred, C., Tekman, M., Stanescu, H., Kleta, R., Lench, N., Chitty, L. S., Scott, R. H. A novel homozygous ERCC5 truncating mutation in a family with prenatal arthrogryposis--further evidence of genotype-phenotype correlation. Am. J. Med. Genet. 164A: 1777-1783, 2014. [PubMed: 24700531, related citations] [Full Text]

  2. Graham, J. M., Jr., Anyane-Yeboa, K., Raams, A., Appeldoorn, E., Kleijer, W. J., Garritsen, V. H., Busch, D., Edersheim, T. G., Jaspers, N. G. J. Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy. Am. J. Hum. Genet. 69: 291-300, 2001. [PubMed: 11443545, images, related citations] [Full Text]

  3. Hamel, B. C. J., Raams, A., Schuitema-Dijkstra, A. R., Simons, P., van der Burgt, I., Jaspers, N. G. J., Kleijer, W. J. Xeroderma pigmentosum-Cockayne syndrome complex: a further case. J. Med. Genet. 33: 607-610, 1996. [PubMed: 8818951, related citations] [Full Text]

  4. Nouspikel, T., Lalle, P., Leadon, S. A., Cooper, P. K., Clarkson, S. G. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function. Proc. Nat. Acad. Sci. 94: 3116-3121, 1997. Note: Retraction Proc. Nat. Acad. Sci. 103: 19606 only, 2006. [PubMed: 9096355, related citations] [Full Text]


Creation Date:
Cassandra L. Kniffin : 9/23/2015
carol : 12/28/2015
alopez : 9/25/2015
ckniffin : 9/23/2015

# 616570

CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3


ORPHA: 1466, 191;   DO: 0080913;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
13q33.1 Cerebrooculofacioskeletal syndrome 3 616570 Autosomal recessive 3 ERCC5 133530

TEXT

A number sign (#) is used with this entry because of evidence that cerebrooculofacioskeletal syndrome-3 (COFS3) is caused by homozygous mutation in the ERCC5 gene (133530) on chromosome 13q33.

Biallelic mutations in the ERCC5 gene can also cause Xeroderma pigmentosum, group G and/or Cockayne syndrome (278780).


Description

Cerebrooculofacioskeletal syndrome is a severe, progressive neurologic disorder characterized by prenatal onset of arthrogryposis, microcephaly, and growth failure. Postnatal features include severe developmental delay, congenital cataracts (in some), and marked UV sensitivity of the skin. Survival beyond 6 years of age is rare. COFS represents the severe end of the spectrum of disorders caused by mutations in nucleotide excision repair (NER) genes, with Cockayne syndrome and xeroderma pigmentosum being milder NER-related phenotypes (summary by Drury et al., 2014).

For a phenotypic description and a discussion of genetic heterogeneity of cerebrooculofacioskeletal syndrome, see COFS1 (214150).


Clinical Features

Hamel et al. (1996) and Nouspikel et al. (1997) studied a male who was born to healthy first-cousin Moroccan parents and had extremely severe early-onset Cockayne syndrome leading to death at 7 months of age. Graham et al. (2001) referred to the case reported by Hamel et al. (1996) as one of cerebrooculofacioskeletal syndrome. The patient showed prenatal-onset growth deficiency, severe microcephaly, microphthalmia with no cataracts, cleft palate, cutaneous photosensitivity, and brain atrophy with no calcifications. Skin fibroblasts showed extreme cellular sensitivity to UV, comparable to that in classic XP.

Drury et al. (2014) reported a family of Pakistani ancestry in which 5 fetuses conceived to 3 pairs of first cousins presented with abnormal ultrasound findings in the second trimester, including contractures and microcephaly. All pregnancies were terminated and underwent autopsy. Variable intracerebral findings included 2 instances of ventriculomegaly, 2 of delayed cerebral sulcation, and 2 of cerebellar hypoplasia/posterior fossa abnormalities. The 1 fetus that survived beyond 24 weeks developed progressive edema. None of the fetuses had cataracts.


Inheritance

The transmission pattern of COFS3 in the family reported by Drury et al. (2014) was consistent with autosomal recessive inheritance.


Mapping

By linkage analysis of a consanguineous Pakistani kindred in which 5 fetuses were affected with COFS, Drury et al. (2014) found linkage to a 9.3-Mb region on chromosome 13q32.3-q33.3 (lod score of 5.0).


Molecular Genetics

In a boy, born of consanguineous Moroccan parents, with COFS originally reported by Hamel et al. (1996), Nouspikel et al. (1997) identified a homozygous truncating mutation in the ERCC5 gene (133530.0003).

In 4 fetuses from a large consanguineous Pakistani kindred with COFS3, Drury et al. (2014) identified a homozygous truncating mutation in the ERCC5 gene (133530.0016) predicting the loss of the C terminus. The mutation, which was found by a combination of linkage analysis and exome sequencing, segregated with the disorder in the family. Functional studies of the variant were not performed.


REFERENCES

  1. Drury, S., Boustred, C., Tekman, M., Stanescu, H., Kleta, R., Lench, N., Chitty, L. S., Scott, R. H. A novel homozygous ERCC5 truncating mutation in a family with prenatal arthrogryposis--further evidence of genotype-phenotype correlation. Am. J. Med. Genet. 164A: 1777-1783, 2014. [PubMed: 24700531] [Full Text: https://doi.org/10.1002/ajmg.a.36506]

  2. Graham, J. M., Jr., Anyane-Yeboa, K., Raams, A., Appeldoorn, E., Kleijer, W. J., Garritsen, V. H., Busch, D., Edersheim, T. G., Jaspers, N. G. J. Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy. Am. J. Hum. Genet. 69: 291-300, 2001. [PubMed: 11443545] [Full Text: https://doi.org/10.1086/321295]

  3. Hamel, B. C. J., Raams, A., Schuitema-Dijkstra, A. R., Simons, P., van der Burgt, I., Jaspers, N. G. J., Kleijer, W. J. Xeroderma pigmentosum-Cockayne syndrome complex: a further case. J. Med. Genet. 33: 607-610, 1996. [PubMed: 8818951] [Full Text: https://doi.org/10.1136/jmg.33.7.607]

  4. Nouspikel, T., Lalle, P., Leadon, S. A., Cooper, P. K., Clarkson, S. G. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function. Proc. Nat. Acad. Sci. 94: 3116-3121, 1997. Note: Retraction Proc. Nat. Acad. Sci. 103: 19606 only, 2006. [PubMed: 9096355] [Full Text: https://doi.org/10.1073/pnas.94.7.3116]


Creation Date:
Cassandra L. Kniffin : 9/23/2015

Edit History:
carol : 12/28/2015
alopez : 9/25/2015
ckniffin : 9/23/2015